Can you interpret the mammogram of a 67-year-old female presenting with unexplained progressive weight loss, back and left hip pain, and a family history of cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mammogram Interpretation in a 67-Year-Old Woman with Unexplained Weight Loss and Pain

Without seeing the actual mammogram images, I cannot provide a specific interpretation, but I can guide you through the standardized BI-RADS classification system that your radiologist will use to categorize any findings and determine next steps. 1

Understanding BI-RADS Categories

Your mammogram will be classified using the Breast Imaging Reporting and Data System (BI-RADS), which provides a uniform reporting structure with specific recommendations for each category 1:

BI-RADS 0 - Incomplete Assessment

  • Additional imaging is needed (spot compression, magnification views, or ultrasound)
  • Prior mammograms should be obtained for comparison
  • This is commonly used in screening situations when a finding requires further evaluation 1

BI-RADS 1 - Negative

  • Completely normal mammogram
  • Breasts are symmetric with no masses, architectural distortion, or suspicious calcifications
  • Action: Return to routine annual screening 1

BI-RADS 2 - Benign Findings

  • Specific benign findings are present (calcifying fibroadenoma, oil cyst, lipoma, vascular calcification, intramammary lymph nodes)
  • No evidence of malignancy
  • Action: Return to routine annual screening 1

BI-RADS 3 - Probably Benign

  • Less than 2% risk of malignancy
  • Findings include circumscribed masses, focal asymmetry, or round calcifications
  • Action: Short-interval follow-up at 6 months, then additional examinations until 2+ years of stability is established 1
  • Important caveat: This category should NOT be used for palpable lesions 1

BI-RADS 4 - Suspicious Abnormality

  • Malignancy risk ranges from 3% to 94%
  • Wide spectrum of suspicious but not definitively malignant findings
  • Action: Tissue biopsy is required (core needle biopsy preferred over fine-needle aspiration) 1, 2

BI-RADS 5 - Highly Suggestive of Malignancy

  • ≥95% probability of cancer
  • Includes spiculated masses or malignant-appearing pleomorphic calcifications
  • Action: Immediate biopsy and appropriate oncologic management 1

BI-RADS 6 - Known Biopsy-Proven Malignancy

  • Reserved for lesions already confirmed as cancer by biopsy but before definitive treatment 1

Critical Context for Your Specific Situation

Given your clinical presentation—unexplained progressive weight loss, back and hip pain, and family history of cancer—several important considerations apply:

If mammography shows BI-RADS 4 or 5 findings:

  • Image-guided core needle biopsy is mandatory 2
  • Ultrasound guidance is preferred when the lesion is visible on both modalities due to real-time visualization, patient comfort, and absence of radiation 2

If mammography is negative or shows only BI-RADS 1-2 findings:

  • Given your unexplained weight loss and pain symptoms, the negative mammogram does NOT rule out systemic disease
  • Your symptoms (progressive weight loss, back pain, hip pain) raise concern for possible metastatic disease from an occult primary tumor or other systemic illness 3, 4
  • The combination of BI-RADS assessment with ultrasound provides the most complete evaluation 1

If any abnormality is identified:

  • The overall BI-RADS category is based on the MOST WORRISOME finding present 1
  • If both mammography and ultrasound are performed, the BI-RADS category represents cumulative findings from both modalities 1

What Happens Next

For BI-RADS 0: You will be called back for additional views or ultrasound before a final assessment can be made.

For BI-RADS 1-2: While breast imaging may be reassuring, your unexplained weight loss and pain symptoms warrant investigation for other causes beyond breast pathology. Your primary care physician should pursue additional workup for these systemic symptoms.

For BI-RADS 3: Short-interval follow-up mammography at 6 months is recommended, but this category should not be used if you have a palpable mass 1.

For BI-RADS 4-5: Immediate tissue sampling via image-guided core needle biopsy is required 2, 5. Do not delay this procedure.

Important Pitfalls to Avoid

  • Never let negative imaging override a highly suspicious clinical presentation 2. The negative predictive value of combined mammography and ultrasound for palpable masses ranges from 97.4% to 100%, but this still means some cancers can be missed 2.

  • Your systemic symptoms (weight loss, bone pain) may indicate disease beyond the breast, including possible metastatic disease from breast or other primary cancers, or non-malignant systemic conditions 3, 4.

  • Ensure concordance between imaging findings and any palpable abnormalities. If there is discordance, biopsy is still indicated 2.

Request a copy of your mammogram report with the specific BI-RADS category and discuss the findings with your physician immediately, especially given your concerning systemic symptoms.

References

Guideline

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis.

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

Guideline

acr appropriateness criteria<sup>®</sup> palpable breast masses.

Journal of the American College of Radiology, 2017

Research

Beyond the breast: Mammographic manifestations of systemic disease.

Current problems in diagnostic radiology, 2026

Guideline

breast cancer screening and diagnosis, version 3.2018, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2018

Related Questions

What is the differential diagnosis for a 34-year-old woman with a strong family history of breast cancer (mother and maternal aunt diagnosed at age 39) presenting with a right axillary/breast lump?
In a 36-year-old woman with a stable, previously excised left breast lump and no high-risk factors, is a screening mammogram, breast MRI, or diagnostic breast ultrasound indicated?
What is the recommended evaluation and management for a 52-year-old woman who had left breast tumor removal surgery last Thursday and now presents with dizziness, fatigue, and pressure behind the ears?
What is the recommended management for a 74-year-old woman with bilateral circumscribed, partially obscured masses on screening mammogram who now has breast pain?
For a 32-year-old woman with dense breast tissue and a family history of breast cancer who had a prior area of asymmetry on screening mammography that was benign on ultrasound and a recent normal diagnostic mammogram, what further evaluation or surveillance (e.g., breast MRI, genetic counseling) is recommended?
What is a comprehensive clerkship—including focused history, physical examination, investigations, and management—for a patient with pulmonary tuberculosis?
What is the appropriate management for bilateral frontal encephalomalacia?
What oral antifungal treatment is recommended for an 11‑month‑old infant with yeast (candidal) diaper rash?
What is the appropriate valacyclovir dosing regimen for suppressive therapy to prevent recurrent herpes simplex virus infections?
Which medications can cause erythema multiforme?
In an elderly male patient in his late 80s currently receiving dofetilide 0.25 mg twice daily, how many milligrams are 125 µg of Tikosyn (dofetilide)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.